Dysfunction of mitochondrial respiratory chain complex I in human failing myocardium is not due to disturbed mitochondrial gene expression - PubMed (original) (raw)
Dysfunction of mitochondrial respiratory chain complex I in human failing myocardium is not due to disturbed mitochondrial gene expression
Robert J Scheubel et al. J Am Coll Cardiol. 2002.
Free article
Abstract
Objectives: Activity of mitochondrial respiratory chain complexes with and without mitochondrially encoded subunits was assessed in failing human myocardium together with parameters of mitochondrial gene expression.
Background: Mutations and deletions in mitochondrial genome (mtDNA) sporadically accumulate in the aging myocardium. In experimental heart failure, they are discussed to be a generalized problem resulting in disturbances of mitochondrial gene expression and mitochondrial function.
Methods: In left ventricular specimens from 43 explanted failing hearts and 10 donor hearts, enzyme activities of respiratory chain complexes, messenger ribonucleic acid (mRNA) expression of mitochondrially and nuclear encoded mitochondrial components (reverse transcriptase-polymerase chain reaction, Northern blot), undeleted wildtype mtDNA (Southern blot), and nuclear encoded mitochondrial transcription factor A (mtTFA) (Western blot) were quantified.
Results: Citrate synthase normalized activity of mitochondrial respiratory chain complex I, which contains seven mitochondrially encoded subunits, was decreased by 28% in terminally failing myocardium, whereas the activity of the exclusively nuclear encoded complex II was unchanged. However, the amount of intact mtDNA, the mRNA of all mitochondrially encoded subunits of the entire respiratory chain, the amount of mtTFA, and the enzymatic activity of complex III and complex IV, which also contain mitochondrially encoded subunits, were normal compared with donor hearts, excluding generalized disturbance of mitochondrial gene expression. Retrospective analysis of drug therapy before transplantation identified beta-blockers as one putative protection against this disturbance.
Conclusions: In terminally failing human myocardium of patients receiving drug therapy, complex I depression is not caused by mtDNA damage and disturbed mitochondrial gene expression. The absence of mtDNA damage should facilitate recovery of the overloaded myocardium, if effective unloading could be achieved.
Comment in
- Mitochondrial dysfunction in heart failure.
Marin-Garcia J. Marin-Garcia J. J Am Coll Cardiol. 2003 Jun 18;41(12):2299; author reply 2299. doi: 10.1016/s0735-1097(03)00494-7. J Am Coll Cardiol. 2003. PMID: 12821264 No abstract available.
Similar articles
- Mitochondrial gene expression is impaired by ethanol exposure in cultured chick cardiac myocytes.
Kennedy JM. Kennedy JM. Cardiovasc Res. 1998 Jan;37(1):141-50. doi: 10.1016/s0008-6363(97)00198-3. Cardiovasc Res. 1998. PMID: 9539868 - Tissue-specific mtDNA lesions and radical-associated mitochondrial dysfunction in human hearts exposed to doxorubicin.
Lebrecht D, Kokkori A, Ketelsen UP, Setzer B, Walker UA. Lebrecht D, et al. J Pathol. 2005 Dec;207(4):436-44. doi: 10.1002/path.1863. J Pathol. 2005. PMID: 16278810 - Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction.
Ide T, Tsutsui H, Hayashidani S, Kang D, Suematsu N, Nakamura K, Utsumi H, Hamasaki N, Takeshita A. Ide T, et al. Circ Res. 2001 Mar 16;88(5):529-35. doi: 10.1161/01.res.88.5.529. Circ Res. 2001. PMID: 11249877 - Mitochondrial-nuclear cross-talk in the aging and failing heart.
Marín-García J, Pi Y, Goldenthal MJ. Marín-García J, et al. Cardiovasc Drugs Ther. 2006 Dec;20(6):477-91. doi: 10.1007/s10557-006-0584-6. Cardiovasc Drugs Ther. 2006. PMID: 17119872 Review. - Mitochondrial oxidative stress and dysfunction in myocardial remodelling.
Tsutsui H, Kinugawa S, Matsushima S. Tsutsui H, et al. Cardiovasc Res. 2009 Feb 15;81(3):449-56. doi: 10.1093/cvr/cvn280. Epub 2008 Oct 14. Cardiovasc Res. 2009. PMID: 18854381 Review.
Cited by
- Journey to find the ideal PET flow tracer for clinical use: are we there yet?
Glover DK, Gropler RJ. Glover DK, et al. J Nucl Cardiol. 2007 Nov-Dec;14(6):765-8. doi: 10.1016/j.nuclcard.2007.09.019. J Nucl Cardiol. 2007. PMID: 18022101 No abstract available. - A comprehensive review of the bioenergetics of fatty acid and glucose metabolism in the healthy and failing heart in nondiabetic condition.
Gupta A, Houston B. Gupta A, et al. Heart Fail Rev. 2017 Nov;22(6):825-842. doi: 10.1007/s10741-017-9623-6. Heart Fail Rev. 2017. PMID: 28536966 Review. - Exercise leads to unfavourable cardiac remodelling and enhanced metabolic homeostasis in obese mice with cardiac and skeletal muscle autophagy deficiency.
Yan Z, Kronemberger A, Blomme J, Call JA, Caster HM, Pereira RO, Zhao H, de Melo VU, Laker RC, Zhang M, Lira VA. Yan Z, et al. Sci Rep. 2017 Aug 11;7(1):7894. doi: 10.1038/s41598-017-08480-2. Sci Rep. 2017. PMID: 28801668 Free PMC article. - Role of Mitochondria and Endoplasmic Reticulum in Taurine-Deficiency-Mediated Apoptosis.
Jong CJ, Ito T, Prentice H, Wu JY, Schaffer SW. Jong CJ, et al. Nutrients. 2017 Jul 25;9(8):795. doi: 10.3390/nu9080795. Nutrients. 2017. PMID: 28757580 Free PMC article. - Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid Improves Energetic Status and Cardiomyogenic Differentiation of Human Dilated Myocardium-Derived Primary Mesenchymal Cells.
Miksiunas R, Rucinskas K, Janusauskas V, Labeit S, Bironaite D. Miksiunas R, et al. Int J Mol Sci. 2020 Jul 8;21(14):4845. doi: 10.3390/ijms21144845. Int J Mol Sci. 2020. PMID: 32650632 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources